A Plain Language Summary of Results from the FLAURA2 Study: Initial (First-Line) Osimertinib Treatment with or Without Chemotherapy in Patients with Untreated EGFR-mutated Advanced NSCLC.
Future oncology (London, England)（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined